Semi-synthetic taxanes with antitumor and antiangiogenetic...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reissue Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C549S510000, C549S511000

Reissue Patent

active

11158323

ABSTRACT:
Seco-baccatin III derivatives of formula:wherein R, R1-R4,delete-start id="DEL-S-00001" date="20070710" ?R1delete-end id="DEL-S-00001" ?insert-start id="INS-S-00001" date="20070710" ?R′insert-end id="INS-S-00001" ?,delete-start id="DEL-S-00002" date="20070710" ?R11delete-end id="DEL-S-00002" ?insert-start id="INS-S-00002" date="20070710" ?R″insert-end id="INS-S-00002" ?, anddelete-start id="DEL-S-00003" date="20070710" ?R111delete-end id="DEL-S-00003" ?insert-start id="INS-S-00003" date="20070710" ?R′″insert-end id="INS-S-00003" ?are disclosed herein; pharmaceutical compositions comprising seco-baccatin III derivative; and methods for treating cancer, arthritis, and inhibiting angiogenesis in an animal comprising administrating to a patient in need thereof a therapeutically effective amount of a seco-baccatin III derivative are disclosed.

REFERENCES:
patent: 5756776 (1998-05-01), Bombardelli et al.
patent: WO 96/03394 (1996-02-01), None
Wang et al., The Oxetane Ring in Taxol, J. Org. Chem., 65:1059-1068 (2000).
Distenfano et al., Antitumor Activity of Paclitaxel (Taxol) Analogs on MDR-positive Human Cancer Cells, Anti-Cancer Drug Design 13(5):489-499 (1998).
Appendino et al., Synthesis and Evaluation of C-seco Paclitaxel Analogs, Tetrahedron Letters, 38(24):4273-4276 (1997). See p. 4274, compounds 5a-5d.
Lainer, et al., “New antiangiogenic strategies for the treatment of proliferative synovitis”, Expert Opinion Investig. Drugs (2005), 14(1), pp. 1-17.
International Search Report of PCT/EP01/00386.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Semi-synthetic taxanes with antitumor and antiangiogenetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Semi-synthetic taxanes with antitumor and antiangiogenetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Semi-synthetic taxanes with antitumor and antiangiogenetic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3789256

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.